D‐Cycloserine facilitates synaptic plasticity but impairs glutamatergic neurotransmission in rat hippocampal slices
D‐Cycloserine facilitates synaptic plasticity but impairs glutamatergic neurotransmission in rat hippocampal slices
复制标题
DOI:
10.1038/sj.bjp.0705541
复制
发表时间:
2003-11
影响因子:
7.3
通讯作者:
E. Rouaud;J. Billard
中科院分区:
文献类型:
--
作者:
E. Rouaud;J. Billard
The glycine‐binding site of the glutamatergicN‐methyl‐D‐aspartate receptor subtype (NMDAr) has been proposed as a putative target for treating cognitive impairments in neurodegenerative disorders and schizophrenia. Although behavioural evidence has been accumulated showing that the partial agonistD‐cycloserine (DCS) facilitated learning and memory, physiological mechanisms of the drug still remained to be characterized. In the present study, we have investigated the effects of DCS on glutamatergic neurotransmission and synaptic plasticity in CA1 region of rat hippocampal slices, using extracellular field excitatory postsynaptic potentials.We showed that DCS facilitated NMDAr‐mediated synaptic potentials. In addition, we found that the magnitude of NMDAr‐dependent long‐term depression was significantly enhanced by the agonist, while the threshold for the induction of lasting potentiations was lowered.We found that DCS decreased neurotransmission mediated byα‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid (AMPA)/kainate subtypes of glutamate receptors. This inhibition was not prevented by theγ‐aminobutyric acid GABAAantagonist bicuculline, but was antagonized by the glycine antagonist strychnine.These results, therefore, show opposite effects of DCS on NMDA and non‐NMDA synaptic responses within the hippocampus. They also demonstrate that DCS facilitates long‐term synaptic plasticity that may support the DCS‐induced enhanced cognitive performances.British Journal of Pharmacology(2003)140, 1051–1056. doi:10.1038/sj.bjp.0705541